|
BPCC2012 Vision
Over the past three years, CDMC Events’ biopharma conference series such as World Clinical Research Organization Summit 2010, Pharma Innovate Asia Taiwan 2010, China Vaccine Focus 2011, World Antibody Focus 2011 etc. have been well received and acclaimed by global participants. In 2012, enlightened by China’s “12th Five Year Plan” on biopharma industry, CDMC Events will present you BioPharma China Convention 2012-Vaccine & Antibody Focuson June 20th-21st in Beijing China with the theme of “Upgrading China’s BioPharma Industry through Innovation and Collaboration”. It is committed to provide a content-rich, critically-focused event with the aim of helping biopharma decision makers and scientists obtain insights into global biopharma trends, China market strategies, partnering & investment opportunities, frontiers in vaccine and antibody R&D, manufacturing & production excellence etc.
Shake Hands with and Listen to World Class Speakers
-
Vaccine Stream |
Antibody Stream |
|
Xiaoping DONG
Director
The Chinese
Center for Disease
Control and
Prevention (CCDC) |
|
Xinliang SHEN
Chairman, ABO
Executive
Committee
Vice President of
China National
Biotech Group |
|
JIN Yulan
President
Changchun
Institute of
Biological
Products |
|
Sean DU
Head & Executive
Director,
Vaccine
Research
Simcere
Pharmaceutical
Groups |
|
Haifa ZHENG
General
Manager
Beijing Minhai
Biotechnology
Co., Ltd |
|
Xiaoqiang (Alex)
LI
General Manager
TASLY& JENNER (Tianjin)
Co., LTD |
|
Nicholas
JACKSON
Senior Director
Pfizer Vaccine
Research |
|
Jean-Denis SHU
Medical Director
Sanofi Pasteur
Biological
Products Co. Ltd. |
|
Xiang (Sam) LIAO
Head
Business
Development& Licensing
Asia
Novartis Vaccines
& Diagnostics, Inc. |
|
Tim Hirst
Executive
Chairman
Gamma
Vaccines |
|
Ales
STRANCAR
CEO
BIA Separations |
|
Samuel THONG
Managing
Director
Morgan Stanley |
|
|
|
|
YAO Jun
Director of the
Planning
Department
MIIT (Ministry
of Industry and
Information
Technology) |
|
Prof. GUO Yajun
Director
Chinese National
Engineering
Research Center
for Antibody
Medicine |
|
ZHANG Aihua
Vice Director R&D
Department
China National
Biotech Group |
|
Dr. ZHANG
Lianshan
Global R&D
President
Jiangsu Hengrui
Medicine Co,.Ltd |
|
Klaus
WILGENBUS
MD
Corporate Senior
Vice President
Boehringer
Ingelheim (BI) |
|
Shirley ZHAO
General
Manager
Genzyme
China |
|
XIA Mingde,
Ph.D.
Senior Director
COSAT
Johnson& Johnson |
|
Dr. John L. XU
Associate
Director,
Biologics
GSK R&D China |
|
Patrick A.
BAEUERLE
Senior Vice
President
Chief
Scientific Office
Micromet |
|
ZHU Zhenping
CEO
Kadmon China |
|
Jin-San YOO
CEO
President
and Founder
PharmAbcine,
Inc., Korea |
|
Andrew
BUCHANAN
PhD
Senior Scientist
and Team Leader
MedImmune |
|
|
|
WHY BPCC-See what your peers said:
- Very nice meeting. Thank organizers very much for the great effort. One of the best vaccine focus conference in china.
SHEN Xinliang, Deputy General Manager, China National Biotech Group
- This is a high quality international conference with excellent group of speakers & participants. Very well organized, provided enough opportunity for people to interact. Looking forward to the future events.
GUO Yajun, Director, Chinese National Engineering Research Centre for Antibody Medicine
- Excellent conference with great mix of speakers. It provided good platform to learn for scientists who are antibody experts and new in the field. Plenty opportunities to interact with old friends and to meet new ones.
ZHU Zhenping, EVP, Kadmon Pharmaceuticals
- This is a very exciting events, with participants from both academia and pharma industry. There is something new for both new-comers to the therapeutics Ab fields and veterans in the industry as well. Great networking opportunities!
Dr. John L. Xu, Associate Director, Biologics, GSK R&D China
- Very professionally organized, good questions and knowledgeable topics.
Dr. Klaus WILGENBUS, Corporate Senior Vice President, Boehringer Ingelheim
- It has been great to find out more detail on the biopharmacautical industry in China.
Andrew Buchanan, Senior Team Leader & Scientist, MedImmun
Conference Structure
|
DAY 1, June 20, Wednesday |
DAY 2, June 21, Tuesday |
AM |
Global Outlook & China Strategies |
Concurrent one-on-one meetings |
Vaccine Stream: |
Antibody Stream |
Concurrent one-on-one meetings |
PM |
Partnering & Investment Opportunities |
See what your can benefit:
- Gaining knowledge of latest information about biopharma and detailed incentive policy of local government
- Talking face-to-face and networking with governmental officials, professionals and scientists home and abroad
- Hosting one-on-one meetings with your potential business partners and promote your business
- Sharing with your peers the latest ideas on biopharma development
- Having an opportunity to publicize your company and future plan
|
|
Organized by
Sponsors
Endorsers
|